Outlook for This Week in the Nation’s Capital - Congress Returns. The House and Senate return from a week-long recess. The House will likely take up two bills aimed at addressing the youth use of vaping devices: one would...more
As far as an industry watchdog group, let’s just say that the American Retirement Association (ARA) does its job. Regardless of party affiliation, the ARA takes on politicians with proposals that are harmful to the retirement...more
Outlook for This Week in the Nation’s Capital - Impeachment Schedule. The House is in recess this week but will continue to hear testimony from a number of witnesses related to the impeachment probe....more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more
This week in Washington: Hearings continue on the price of prescription drugs, Senate Committee on Finance to hold a hearing on Medicare physician payment reform, while the Senate HELP Committee will hold its second hearing...more
Outlook for This Week in the Nation's Capital - Congress: House Democrats directed their pent up ire at President Donald Trump towards Attorney General Barr last week, after he refused to come testify before the House...more
Below is the Federal Policy team’s weekly preview, published when Congress is in session. HEADLINES - • Congress returns this week from a two-week recess, with the House continuing to showcase Democrats’ legislative...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. DRUG PRICES: CONGRESS RETURNS, PICKS UP WHERE LAWMAKERS LEFT OFF - Congress reconvenes today after a...more
Outlook for This Week in the Nation's Capital - Congress. After a frantic first three months, the House and Senate have now adjourned for a much needed two week recess, with many questions remaining on how various...more
Congress - Hearings/Markups - Senate Finance Committee: "Drug Pricing in America: A Prescription for Change, Part III" - Tuesday, April 9, 2019: The Senate Finance Committee continued its drug pricing series by...more
If you track national health care policy developments, you’ve been busy lately. Following weeks of growing declarations from Democrats in support of Medicare for All, US House Speaker Nancy Pelosi tamped down exuberance...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. GOTTLIEB, HARGAN TO TESTIFY ON 2020 HEALTH BUDGET, PROGRAMS - Outgoing FDA Commissioner Scott Gottlieb and...more
First in a series. Like it or not, the 2020 presidential election campaign is well underway. With it comes the latest in public policy ideas, including more attempts to overhaul health care in the U.S....more
Recently, progressive democrats in the House of Representatives lead by Rep. Pramila Jayapal (D-WA) and Debbie Dingell (D-MI) released the long-awaited Medicare for All Act of 2019 (M4A) proposal. M4A differs from...more
This week, seven top executives from drug manufacturers will testify in a highly anticipated hearing before the Senate Finance Committee. These companies will be questioned regarding rising drug prices, transparency, patent...more
Health care issues will remain a central focus in Washington throughout 2019. Having gained control of the House following the 2018 mid-term elections, Democrats now have the ability to block President Trump's legislative...more